Potent tricyclic pyrazole tetrazole agonists of the nicotinic acid receptor (GPR109a)

被引：29
|
作者：
Boatman, P. Douglas [1 ]
Schrader, Thomas O. [1 ]
Kasem, Michelle [1 ]
Johnson, Benjamin R. [1 ]
Skinner, Philip J. [1 ]
Jung, Jae-Kyu [1 ]
Xu, Jerry [1 ]
Cherrier, Martin C. [1 ]
Webb, Peter J. [1 ]
Semple, Graeme [1 ]
Sage, Carleton R. [1 ]
Knudsen, Jens [1 ]
Chen, Ruoping [2 ]
Taggart, Andrew K. [3 ]
Carballo-Jane, Ester [3 ]
Richman, Jeremy G. [2 ]
机构：
[1] Arena Pharmaceut, Dept Med Chem, San Diego, CA 92121 USA
[2] Arena Pharmaceut, Dept Discovery Biol, San Diego, CA 92121 USA
[3] Merck Res Labs, Rahway, NJ USA
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2010年 / 20卷 / 09期
关键词：
Niacin receptor; Free fatty acids; Vasodilation; Atherosclerosis; TERMINAL EPOXIDES; PROSTAGLANDIN D-2; LANGERHANS CELLS; NIACIN; MK-0354; DISEASE; HUMANS; DRUG; MICE;
D O I：
10.1016/j.bmcl.2010.03.062
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Tricyclic pyrazole tetrazoles which are potent partial agonists of the high affinity niacin receptor, GPR109a, have been discovered and optimized. One of these compounds has proven to be effective at lowering free fatty acids in vitro and in vivo. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码：2797 / 2800
页数：4
相关论文
共 49 条
  • [31] Discovery of Novel Tricyclic Full Agonists for the G-Protein-Coupled Niacin Receptor 109A with Minimized Flushing in Rats
    Shen, Hong C.
    Ding, Fa-Xiang
    Deng, Qiaolin
    Wilsie, Larissa C.
    Krsmanovic, Mihajlo L.
    Taggart, Andrew K.
    Carballo-Jane, Ester
    Ren, Ning
    Cai, Tian-Quan
    Wu, Tsuei-Ju
    Wu, Kenneth K.
    Cheng, Kang
    Chen, Qing
    Wolff, Michael S.
    Tong, Xinchun
    Holt, Tom G.
    Waters, M. Gerard
    Hammond, Milton L.
    Tata, James R.
    Colletti, Steven L.
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (08) : 2587 - 2602
  • [32] The psoriasis drug monomethylfumarate is a potent nicotinic acid receptor agonist
    Tang, Hua
    Lu, Jenny Ying-Lin
    Zheng, Xiaomu
    Yang, Yuhua
    Reagan, Jeff D.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 375 (04) : 562 - 565
  • [33] 5-N,N-Disubstituted 5-aminopyrazole-3-carboxylic acids are highly potent agonists of GPR109b
    Skinner, Philip J.
    Webb, Peter J.
    Sage, Carleton R.
    Dang, Huong T.
    Pride, Cameron C.
    Chen, Ruoping
    Tamura, Susan Y.
    Richman, Jeremy G.
    Connolly, Daniel T.
    Semple, Graeme
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (15) : 4207 - 4209
  • [34] Niacin receptor GPR109A inhibits insulin secretion and is down-regulated in type 2 diabetic islet beta-cells
    Wang, Na
    Guo, De-yu
    Tian, Xiong
    Lin, Hao-peng
    Li, Yun-pan
    Chen, Shao-jun
    Fu, Yu-cai
    Xu, Wen-can
    Wei, Chi-ju
    GENERAL AND COMPARATIVE ENDOCRINOLOGY, 2016, 237 : 98 - 108
  • [35] GSK256073, a selective agonist of G-protein coupled receptor 109A (GPR109A) reduces serum glucose in subjects with type 2 diabetes mellitus
    Dobbins, R. L.
    Shearn, S. P.
    Byerly, R. L.
    Gao, F. F.
    Mahar, K. M.
    Napolitano, A.
    Nachbaur, G. J.
    de Gouville, A. -C. Le Monnier
    DIABETES OBESITY & METABOLISM, 2013, 15 (11) : 1013 - 1021
  • [36] (1aR,5aR)1a,3,5,5a-Tetrahydro-1H-2,3-diaza-cyclopropa[a]pentalene-4-carboxylic Acid (MK-1903): A Potent GPR109a Agonist that Lowers Free Fatty Acids in Humans
    Boatman, P. Douglas
    Lauring, Brett
    Schrader, Thomas O.
    Kasem, Michelle
    Johnson, Benjamin R.
    Skinner, Philip
    Jung, Jae-Kyu
    Xu, Jerry
    Cherrier, Martin C.
    Webb, Peter J.
    Semple, Graeme
    Sage, Carleton R.
    Knudsen, Jens
    Chen, Ruoping
    Luo, Wen-Lin
    Caro, Luzelena
    Cote, Josee
    Lai, Eseng
    Wagner, John
    Taggart, Andrew K.
    Carballo-Jane, Ester
    Hammond, Milton
    Colletti, Steven L.
    Tata, James R.
    Connolly, Daniel T.
    Waters, M. Gerard
    Richman, Jeremy G.
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (08) : 3644 - 3666
  • [37] 5-Aminosalicylic Acid Azo-Coupled with a GPR109A Agonist Is a Colon-Targeted Anticolitic Codrug with a Reduced Risk of Skin Toxicity
    Jeong, Seongkeun
    Lee, Hanju
    Kim, Soojin
    Ju, Sanghyun
    Kim, Wooseong
    Cho, Heeyeong
    Kim, Hyun Young
    Heo, Gwangbeom
    Im, Eunok
    Yoo, Jin-Wook
    Yoon, In-Soo
    Jung, Yunjin
    MOLECULAR PHARMACEUTICS, 2020, 17 (01) : 167 - 179
  • [38] Niacin mitigates blood-brain barrier tight junctional proteins dysregulation and cerebral inflammation in ketamine rat model of psychosis: Role of GPR109A receptor
    Ibrahim, Weam W.
    Sayed, Rabab H.
    Kandil, Esraa A.
    Wadie, Walaa
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2022, 119
  • [39] Annulation reaction enables the identification of an exocyclic amide tricyclic chemotype as retinoic acid Receptor-Related orphan receptor gamma (RORγ/RORc) inverse agonists
    Marcoux, David
    Bertrand, Myra Beaudoin
    Weigelt, Carolyn A.
    Yip, Shiuhang
    Galella, Michael
    Park, Hyunsoo
    Wu, Dauh-Rurng
    Wang, Jinhong
    Yarde, Melissa
    Cvijic, Mary Ellen
    Li, Sha
    Hynes, John, Jr.
    Tino, Joseph A.
    Zhao, Qihong
    Dhar, T. G. Murali
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (19)
  • [40] Improving metabolic stability with deuterium: The discovery of GPU-028, a potent free fatty acid receptor 4 agonists
    Li, Zheng
    Xu, Xue
    Li, Gang
    Fu, Xiaoting
    Liu, Yanzhi
    Feng, Yufeng
    Wang, Mingyan
    Ouyang, Yunting
    Han, Jing
    BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (24) : 6647 - 6652
12345